March 9, 2026 · Form 4 insider transaction
Ragosa Mark bought 10,360 shares of Kiniksa Pharmaceuticals Ltd. at $26.74 per share, a transaction worth $277.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.